Cargando…

A prospective randomized study comparing concurrent chemoradiation with weekly and 3 weekly cisplatin in locally advanced oropharyngeal carcinoma

INTRODUCTION: The chemotherapy schedules with cytotoxic dose or weekly regimes are still challenging, weighing the benefits versus toxicities. This prospective randomized study is an attempt to assess the efficacy of two schedules of cisplatin in management of locally advanced HNSCC. OBJECTIVES: The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nanda, R., Katke, Aradhana, Suneetha, N., Thejaswini, B., Pasha, Tanvir, Jagannath, K. P., Giri, G. V., Babu, K. Govind
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	ORIGINAL ARTICLE: Head and Neck Cancers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699241/ https://www.ncbi.nlm.nih.gov/pubmed/31489293 http://dx.doi.org/10.4103/sajc.sajc_270_18

Ejemplares similares

Weekly vs. tri-weekly cisplatin based chemoradiation in carcinoma cervix: a prospective randomized study of toxicity and compliance
por: Katke, Aradhana, et al.
Publicado: (2021)

Ten years survival results of randomized study comparing weekly vs. triweekly cisplatin with concurrent radiation in locally advanced carcinoma cervix
por: Nanda, R, et al.
Publicado: (2023)

Standard chemoradiation versus intensity-modulated chemoradiation: a quality of life assessment in oropharyngeal cancer patients
por: Mowry, Sarah E., et al.
Publicado: (2009)

Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinoma
por: Judy, Greg D., et al.
Publicado: (2018)

Long term results of comparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer
por: Gupta, Pramod Kumar, et al.
Publicado: (2016)

Matched pair analysis for comparison of survival outcome of alternative regimens to standard three-weekly cisplatin-based concurrent chemoradiation of head and neck cancer
por: Han, Hye Ri, et al.
Publicado: (2021)

Emotional Quality of Life After Radiation Therapy for Oropharyngeal Carcinoma
por: Rajeev-Kumar, Greeshma, et al.
Publicado: (2019)

The impact of 2 weeks wait referral on survival of head and neck cancer patients
por: Rovira, Aleix, et al.
Publicado: (2023)

Radiation-Induced Hypothyroidism After Radical Intensity Modulated Radiation Therapy for Oropharyngeal Carcinoma
por: Kamal, Mona, et al.
Publicado: (2019)

Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and review
por: PUTTEN, L., et al.
Publicado: (2015)

Effect of vocal rehabilitation after chemoradiation for non-laryngeal head and neck cancers
por: Sreenivas, Athulya, et al.
Publicado: (2021)

Management of clinically N0 neck in oropharyngeal carcinoma
por: Jouhi, Lauri, et al.
Publicado: (2019)

Costs of oropharyngeal squamous cell cancer treatment in Finland
por: Tikkanen, Juhana, et al.
Publicado: (2023)

Chemoradiation for advanced hypopharyngeal carcinoma: a retrospective study on efficacy, morbidity and quality of life
por: Keereweer, Stijn, et al.
Publicado: (2011)

Unravelling the risk factors that underlie oral and oropharyngeal surgery in elderly
por: MOLTENI, G., et al.
Publicado: (2018)

Incidental uptake of fluorodeoxyglucose in the Waldeyer’s ring and risk of oropharyngeal malignancy
por: Bujoreanu, Iulia, et al.
Publicado: (2021)

Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas
por: Vijayvargiya, Pooja, et al.
Publicado: (2022)

A comparative study of treatment outcome in younger and older patients with locally advanced oral cavity and oropharyngeal cancers treated by chemoradiation
por: Biswas, Rituparna, et al.
Publicado: (2019)

Surgery and postoperative radiotherapy a valid treatment for advanced oropharyngeal carcinoma
por: Lybak, Stein, et al.
Publicado: (2010)

Cost analysis in oral cavity and oropharyngeal reconstructions with microvascular and pedicled flaps
por: DEGANELLO, A., et al.
Publicado: (2013)

Intraoperative free margins assessment of oropharyngeal squamous cell carcinoma with confocal laser endomicroscopy: a pilot study
por: Sievert, Matti, et al.
Publicado: (2021)

Assessment of oral mucositis during concurrent chemoradiation of head and neck cancers using patient-reported measurement scale
por: Chaitanya, Nallan CSK, et al.
Publicado: (2018)

Trans-oral robotic surgery for the management of oropharyngeal carcinomas: a 9-year institutional experience
por: MECCARIELLO, G., et al.
Publicado: (2019)

Prevalence of swallowing and speech problems in daily life after chemoradiation for head and neck cancer based on cut-off scores of the patient-reported outcome measures SWAL-QOL and SHI
por: Rinkel, Rico N., et al.
Publicado: (2015)

Bilateral versus ipsilateral neck dissection in oral and oropharyngeal cancer with contralateral cN0 neck
por: Knopf, Andreas, et al.
Publicado: (2020)

The accuracy of clinical neck staging for p16-positive and negative oropharyngeal cancer and its therapeutic implications
por: Hussain, Timon, et al.
Publicado: (2022)

A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer
por: Frankart, Andrew J., et al.
Publicado: (2022)

The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy
por: MORBINI, P., et al.
Publicado: (2019)

Comparison of PD-L1 expression in squamous cell cancer of unknown primary and oropharyngeal squamous cell carcinoma
por: Schmidl, Benedikt, et al.
Publicado: (2022)

Stem cell markers in oral and oropharyngeal squamous cell carcinomas in relation to the site of origin and HPV infection: clinical implications
por: Rizzo, Davide, et al.
Publicado: (2020)

Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma
por: Weiss, Bernhard G., et al.
Publicado: (2020)

Prophylactic exercises among head and neck cancer patients during and after swallowing sparing intensity modulated radiation: adherence and exercise performance levels of a 12-week guided home-based program
por: Cnossen, Ingrid C., et al.
Publicado: (2016)

Late toxicities among laryngopharyngeal cancers patients treated with different schedules of concurrent chemoradiation at a rural tertiary cancer care center
por: Muttath, Geetha, et al.
Publicado: (2019)

A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
por: Balk, Matthias, et al.
Publicado: (2023)

Development of a prognostic model of overall survival in oropharyngeal cancer from real-world data: PRO.M.E.THE.O.
por: Miccichè, Francesco, et al.
Publicado: (2022)

Prospective randomized trial to compare the outcome and tolerability of delivering the same total dose of radiation in 61/2 weeks versus 51/2 weeks time in head and neck cancers
por: Gupta, Manoj, et al.
Publicado: (2015)

Deployment of cisplatin in Veterans with oropharyngeal cancer: toxicity and impact on oncologic outcomes
por: Soliman, Ola, et al.
Publicado: (2023)

Staging and prognosis of oropharyngeal carcinoma according to the 8th Edition of the American Joint Committee on Cancer Staging Manual in human papillomavirus infection
por: Yamashita, Yukashi, et al.
Publicado: (2018)

Phase IIb trial comparing two concurrent cisplatin schedules in locally advanced head and neck cancer
por: Nair, Lekha Madhavan, et al.
Publicado: (2017)

Outcomes following oropharyngeal squamous cell carcinoma resection and bilateral neck dissection with or without contralateral postoperative radiotherapy of the pathologically node-negative neck
por: Jansen, Florian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6n8qr1l61kdqd6e0pr1rgmdec1